CURIS, INC. Debt Securities, Available-for-sale, Allowance for Credit Loss
CURIS, INC. (CRIS) had Debt Securities, Available-for-sale, Allowance for Credit Loss of $0 as of 2024-06-30, per its 10-Q filed 2024-08-01.
Financial Statements › Notes › Credit Losses
us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss · last filed 2025-03-31
- 2024-06-30: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2024-03-31: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2023-12-31: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2023-09-30: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
| Period end | Debt Securities, Available-for-sale, Allowance for Credit Loss |
|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-08 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |